| Price | 9.55p on 21-04-2026 at 12:07:37 |
|---|---|
| Change | 0.15p 1.6% |
| Buy | 9.70p |
| Sell | 9.40p |
| Last Trade: | Sell 16,622.00 at 9.535p |
| Day's Volume: | 682,850 |
| Last Close: | 9.40p |
| Open: | 9.40p |
| ISIN: | GB00BYV81293 |
| Day's Range | 9.40p - 9.55p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £102.03m |
| VWAP: | 9.462664p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 16,622 | 9.535p | Ordinary |
13:07:35 - 21-Apr-26 |
| Sell* | 41,914 | 9.535p | Ordinary |
12:57:56 - 21-Apr-26 |
| Sell* | 50,000 | 9.4333p | Ordinary |
11:26:10 - 21-Apr-26 |
| Unknown* | 8,877 | 9.55p | Ordinary |
11:25:47 - 21-Apr-26 |
| Sell* | 100 | 9.40p | SI Trade |
11:20:51 - 21-Apr-26 |
| Buy* | 20 | 9.70p | SI Trade |
11:20:51 - 21-Apr-26 |
| Buy* | 800 | 9.70p | SI Trade |
11:20:51 - 21-Apr-26 |
| Buy* | 1,000 | 9.70p | SI Trade |
11:20:51 - 21-Apr-26 |
| Sell* | 52,672 | 9.485p | Ordinary |
11:17:30 - 21-Apr-26 |
| Buy* | 1,000 | 9.64p | Ordinary |
10:23:05 - 21-Apr-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |
| 21st Jan 2026 7:00 am | RNS | Q4 2025 Trading Update |
